{"schema_version":"secwatch.filing_event.v1","accession":"0001683168-24-006898","form_type":"8-K","ticker":"CSDX","cik":"0001106861","company_name":"CS DIAGNOSTICS CORP.","filed_at":"2024-10-03T23:59:59+00:00","discovered_at":"2026-05-14T18:03:07.686013+00:00","generated_at":"2026-05-30T21:07:55.122559+00:00","sec_items":["8.01"],"event_type":"other","sentiment":"neutral","materiality_score":0.1,"calibrated_materiality_score":0.1,"confidence":"low","headline":"CS Diagnostics files 8-K describing business and CS Protect Hydrogel product","bullets":["Filing provides general overview of CS Diagnostics Corp. as a medical distribution company.","Highlights CS Protect Hydrogel spacer gel for prostate cancer radiation therapy.","No specific financial results, contracts, approvals, or material events reported.","Lists company officers but no changes to leadership are disclosed."],"urls":{"canonical":"https://secwatch.observer/filing/0001683168-24-006898","json":"https://secwatch.observer/filing/0001683168-24-006898.json","markdown":"https://secwatch.observer/filing/0001683168-24-006898.md","text":"https://secwatch.observer/filing/0001683168-24-006898.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1106861/000168316824006898/0001683168-24-006898-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1106861/000168316824006898/csdiag_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-30T21:07:55.122559+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}